TranS1 Reaches Distribution Agreement in China FeaturedWritten by Jaimie Oh | October 10, 2012
TranS1 has reached a distribution agreement with Beijing Jiade Sunshine.
The distribution agreement covers the sale of AxiaLIF products in China with the exception of Hong Kong, Macau and Taiwan. TranS1's AxiaLIF implants were granted a registration certificate by China's State Food and Drug Administration, and the remaining instrumentation is expected to receive their respective registration in the fourth quarter of 2012.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.